What is the role of octaplas (Octapharma) in the treatment of thrombotic thrombocytopenic purpura (TTP)?

Updated: May 25, 2021
  • Author: Theodore Wun, MD, FACP; Chief Editor: Srikanth Nagalla, MD, MS, FACP  more...
  • Print

Octaplas (Octapharma), a blood plasma product extensively used in Europe, was approved by the FDA in 2013 for use in the United States. The product is a sterile, frozen solution of pooled human plasma from several donors. It is a viable alternative to single-donor plasma, and it is treated with a solvent detergent process, which reduces the risk of infection. The FDA based approval on clinical studies of patients with liver disease, liver transplant, heart surgery, and TTP. [6]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!